Medical Imaging Control Technique Based on Natural Language Request

The USPTO has published a patent application (US20260088156A1) from Siemens Healthineers AG detailing a technique for controlling medical imaging using natural language requests processed by large language models (LLMs). This application outlines a method for generating control signals for medical imaging preparation, execution, or processing based on user input.

Patent Application for Pathology Image Analysis Method

The USPTO has published a patent application (US20260088157A1) detailing a method for analyzing pathology image data. The invention focuses on identifying sets of image elements representative of sample properties using confidence scores and thresholds for pathology analysis.

Patent Application: Predicting Care Coordination Data Using EHR Machine Learning

The USPTO has published a patent application detailing a method for predicting care coordination data using EHR machine learning. The application, filed by Judith Payne and Jody Sheehan Garey, aims to improve scheduling and resource allocation by estimating patient acuity levels and care durations.

AI-Based Medical Patient Service System and Ecosystem Patent Application

The USPTO has published a patent application (US20260088162A1) for an AI-based medical patient service system. The system aims to manage patient requests, route them to appropriate personnel using AI, and includes features like financial incentives and gamification for staff.

Patent Application US20260088163A1: Simulated Peripheral Connections to Capital Equipment

The USPTO has published a new patent application, US20260088163A1, detailing a system for simulated peripheral connections to medical capital equipment. The application, filed on September 24, 2025, describes an adapter designed to authenticate peripheral devices by packaging their data in a format representative of a single-use device.

Automated Surgical Costing System with Staff Tracking

The USPTO has published a patent application (US20260088158A1) for an automated case costing system for surgical procedures. The system, assigned to Ospitek, Inc., tracks staff locations in real-time and analyzes staffing costs based on actual time spent in different areas of a surgery center.

Personalized Avatar Responsive to User State

The USPTO has published a patent application (US20260088164A1) for a system that provides personalized avatars responsive to a user's physiological state and context. The system uses biochemical information and biomarkers to adapt the avatar's appearance, potentially for guidance during programs or routines.

Ultrasound imaging remote access method patent application

The USPTO has published a patent application from SAMSUNG MEDISON CO., LTD. for a method of remotely accessing ultrasound imaging apparatus. The application details a process for activating and terminating remote access in sync with the start and end of an ultrasonic examination.

Client-Advisor Portal System Patent Application

The USPTO has published a patent application (US20260088166A1) filed by Vell LLC on September 22, 2025. The application describes systems and methods for active client monitoring by advisors, particularly in a healthcare context, involving sensor data, alerts, and rule modifications.

Cloud System for Optimizing Medical Study Transfer Imaging Workflows

The USPTO has published a patent application (US20260088167A1) detailing a cloud-based system designed to optimize the performance of imaging workflows for transferring medical studies. The system aims to improve the efficiency of study transfers to viewing applications.

Senior Living Engagement Platform Patent Application

The USPTO has published a patent application (US20260088168A1) for a senior living engagement and care support platform. The application, filed on December 3, 2025, describes a system designed to facilitate senior user engagement and provide updates to caregivers.

System and Method for Detection of Disease using Machine Learning

The USPTO has published a new patent application (US20260088169A1) detailing systems and methods for detecting systemic disease from bacterial samples using machine learning. The application, filed by inventors Mark Driscoll and Daniel Fasulo, focuses on correlating microbiome sequence data with disease states or risk.

AI-Based Radiomics Method for Predicting Disease Onset

The USPTO has published a patent application (US20260088170A1) detailing an AI-based radiomics method for predicting human disease onset using neural networks and color space analysis. The application, filed by Shubham Chandra, describes a non-invasive approach combining CNNs with CIELAB color space transformation for early disease detection and personalized diagnostics.

AGP Intelligent Interpretation and Insulin Adjustment Method

The USPTO has published a patent application from Northeastern University detailing an ambulatory glucose profile (AGP) intelligent interpretation and insulin adjustment method. This method utilizes an expert system to analyze patient data and provide decision support for basal and mealtime insulin adjustments.

Ophthalmic System and Behavior Modification Support Method Patent Application

The USPTO has published a patent application (US20260088172A1) for an ophthalmic system and behavior modification support method assigned to Topcon Corporation. The application describes a system involving patient and medical institution terminals to manage information sharing and communication, with a function to prompt behavior modification for disease treatment based on personality test results.

Patent Application: Explainable AI for Medical Decisions

The USPTO has published a patent application (US20260088173A1) detailing methods and systems for evaluating the faithfulness of explainable AI in medical decision-making. The application focuses on fine-tuning classifiers and ensuring explainer model fidelity for downstream tasks.

Patent Application: Model for Detecting Atrial Fibrillation and Sleep Apnea

The USPTO has published a patent application (US20260088174A1) for a method of establishing a model to detect atrial fibrillation and sleep apnea using machine learning. The application details a process involving training electrocardiograms, feature extraction, and symptom labeling.

Patent Application: Inferring Patient Condition Using Machine Learning

The USPTO has published a patent application (US20260088175A1) filed by Hill-Rom Services, Inc. The application details a machine learning system designed to infer a patient's condition using sensor data and response variable data. This technology aims to improve patient monitoring and diagnostics.

NEC Corporation Patent Application for Estimation Device

The USPTO has published a patent application from NEC Corporation for an estimation device. The application, filed on December 2, 2025, describes a system that extracts gait waveform features to estimate a user's physical condition based on their attributes.

NEC Patent Application for Estimation Device and System

The USPTO has published a patent application from NEC Corporation for an estimation device and system. The application, filed on December 3, 2025, describes a system that extracts feature amounts from gait waveforms to estimate a user's physical condition based on their attributes.

NEC Corporation Patent for AI Assessment Support System

The USPTO has published a patent application by NEC Corporation for an AI assessment support system. The system uses machine learning to predict patient assessment vectors and identify similar patients based on nursing record data.

Patent Application for Medical Imaging Image Processing

The USPTO has published a new patent application (US20260087616A1) from Canon Medical Systems Corporation for a method of processing image data in medical imaging systems. The application details a technique using neural networks to improve image quality from input data, potentially enhancing diagnostic capabilities.

Health Future Projector Patent Application Filed

The USPTO has published a patent application (US20260088179A1) filed by Toyota Research Institute, Inc. The application describes a 'Health Future Projector' system that uses AI to predict future health information and generate visualizations for users based on their demographic, health, and behavioral data.

Patent for Long Term Care Facility Ecosystem and Platform

The USPTO has published a patent application for an ecosystem and platform designed for long-term care facilities. The application, filed by BioLink Systems LLC, aims to improve medical data flow, staff compensation, and overall operations within nursing homes.

Patent Application: Predicting ICU Patient Length of Stay

The USPTO has published a new patent application (US20260088160A1) detailing methods and systems for predicting a patient's length of stay in an intensive care unit (ICU). The application describes improved predictive models that analyze patient data to generate LOS predictions.

Method for Preparing Indigo or Substituted Derivative

The USPTO has published a patent application (US20260085042A1) detailing a method for synthesizing indigo or substituted derivatives. The application, filed on June 16, 2023, describes a process involving anthranilic acid and glyoxylic acid under hydrogenation with a metal catalyst.

Patent Application: Initiator Mixture and Polymer Composition

The USPTO has published a new patent application (US20260085043A1) detailing an initiator mixture, a composition including it, and a polymer formed from the composition. The application was filed on September 18, 2025, by inventors from South Korea.

Patent Application for 4-Amino-5-Methyl Pyridin-2-One Production Process

The USPTO has published a patent application (US20260085044A1) detailing an improved process for producing 4-amino-5-methyl-(1H)-pyridin-2-one and its derivatives. The application, filed by MinAscent Technologies GmbH, describes a method using ammonium salts under pressure without gaseous ammonia, aiming for high yield and purity while reducing container corrosion.

Salts and Solid Forms of 4-hydroxy-N,N-diisopropyltryptamine

The USPTO has published a patent application detailing new salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine (4-OH-DIPT), including hemi-glutarate and hemi-succinate forms. These forms are disclosed for their potential use in treating neurological and psychiatric disorders.

Patent Application for Nitrogen-Containing Heterocyclic Derivative Inhibitor

The USPTO has published a patent application (US20260085045A1) for a nitrogen-containing heterocyclic derivative inhibitor. The application details a compound, its preparation method, and its use in treating diseases such as cardiovascular and cerebrovascular conditions.

Patent Application: Dual Function Compounds for Cancer Treatment

The USPTO has published patent application US20260085046A1, filed on August 7, 2025, for dual function compounds intended for cancer treatment. The application discloses compounds of Formula (I) and their use in treating cancer.

Triphenylazole Compound Patent Application for Synucleinopathy Treatment

The USPTO has published a patent application (US20260085047A1) filed by Shiratori Pharmaceutical Co., Ltd. for a triphenylazole compound intended for the treatment or prevention of synucleinopathy. The application details the compound's structure and its potential use in pharmaceutical compositions.

ACSS2 Inhibitors for Cancer, Alcoholism, Viral Infections

The USPTO has published a patent application (US20260085048A1) detailing novel ACSS2 inhibitors and their potential uses in treating cancer, alcoholism, and viral infections. The application was filed on September 8, 2025.

Ergothioneine Crystal Form Patent Application

The USPTO has published a patent application (US20260085049A1) for a novel crystal form of ergothioneine and its preparation method. The application details a method for producing high-purity ergothioneine with low moisture content, intended for use in dietary supplements, foods, and cosmetics.

Triple Kinase Inhibitors for Cancer Treatment

The USPTO has published a patent application (US20260085050A1) for triple kinase inhibitor compounds designed for cancer treatment. The application details compounds that inhibit EGFR, ALK, and MET simultaneously, along with methods for treating cancer using these inhibitors.

Patent Application for 2-Chloro-4-Fluoro-5-Nitrobenzoic Acid Preparation

The USPTO has published a patent application (US20260085051A1) detailing a novel nitration process for preparing 2-chloro-4-fluoro-5-nitrobenzoic acid. The assignee is ADAMA AGAN LTD. This compound is used in the synthesis of the herbicide saflufenacil.

Patent Application for Furan Derivative Oxidation Process

The USPTO has published a patent application (US20260085052A1) detailing a new process for producing 2,5-furandicarboxylic acid. The application, filed by David Lee Sikkenga and Jan Hendrik Blank, describes a specific oxidation method involving furan derivatives, oxidants, solvents, and catalysts.

Patent Application for Benzofuran Derivatives as SIK Inhibitors

The USPTO has published a patent application (US20260085053A1) from BEONE MEDICINES I GMBH for benzofuran derivatives that act as SIK inhibitors. These compounds are intended for the treatment of various inflammatory diseases.

Hispidin Derivative Synthesis Method and Use

The USPTO has published a patent application (US20260085054A1) detailing a new method for synthesizing Hispidin derivatives and their use in preparing lipid-lowering drugs. The application describes a process using readily available starting materials with potential for large-scale industrial application.

Patent Application for Recyclable Polymer Material and Monomer

The USPTO has published a patent application (US20260085055A1) for a novel monomer and a chemically recyclable polymer material comprising the same. The application, filed by the Korea Institute of Science and Technology, describes a monomer formed by bonding a pentagonal cyclic olefin molecule with a photosensitive molecule to enable chemical recycling.

OX1 Receptor Antagonists Patent Application

The USPTO has published a new patent application (US20260085056A1) filed on May 9, 2025, by NXERA PHARMA UK LIMITED. The application relates to novel compounds for treating neurological or psychiatric disorders associated with orexin receptors.

Patent Application US20260085058A1 for SOS1 Degraders Treating Cancers

The USPTO has published patent application US20260085058A1, which relates to compounds that degrade son of sevenless homolog 1 (SOS1) and their use in treating cancers, particularly KRAS-mutant cancers. The application was filed on August 11, 2023.

System for updating medical facility uses AI

The USPTO has published a patent application for a system that uses AI to determine whether to update a medical facility. The system retrieves information from the facility, applies an AI model, and initiates maintenance or upgrades based on the determination. The application was filed on September 4, 2023.

Patent Application: Therapeutic Compounds - Orexin-1 Receptor Antagonists

The USPTO has published a new patent application (US20260085060A1) for therapeutic compounds that act as orexin-1 receptor antagonists. The application, filed on September 25, 2025, details compounds with structural formula (I), their preparation, and pharmaceutical uses.

Patent Application: Phthalazine Derivatives as Pyruvate Kinase Modulators

The USPTO has published a new patent application (US20260085061A1) for phthalazine derivatives as pyruvate kinase modulators, assigned to Sitryx Therapeutics Limited. The application was filed on September 25, 2025.

Novel compounds as CK2 inhibitors for disease treatment

The USPTO has published a patent application (US20260085062A1) for novel compounds identified as CK2 inhibitors. These compounds are intended for the treatment and prevention of various diseases, including cancer, viral infections, and neurodegenerative disorders. The application details specific chemical structures and their potential pharmaceutical uses.

Patent Application: Benzamide Compounds for SARS-CoV-2 PLpro Inhibition

The USPTO has published a new patent application (US20260085063A1) detailing benzamide compounds and methods for inhibiting SARS-CoV-2 PLpro. The application was filed on August 19, 2025, by inventors Jun Wang, Bin Tan, and Prakash Daulat Jadhav.

Patent Application: Benzofuranyl/Benzoxazolyl Compounds for Cancer Treatment

The USPTO has published a patent application (US20260085064A1) for substituted benzofuranyl and benzoxazolyl compounds, including their synthesis and use in treating cancer. The application was filed on May 2, 2025, by inventors from institutions including the University of Texas MD Anderson Cancer Center.

Patent for SGLT Inhibitor Synthesis Intermediate

The USPTO has published a patent application for a crystalline form of an intermediate useful in the synthesis of SGLT inhibitors. The application details a method to improve purification efficiency and minimize related substances in the final product, potentially increasing yield.

LRRK2 Degrading Compounds for Parkinson's Disease Treatment

The USPTO has published a new patent application (US20260085066A1) detailing bifunctional compounds designed to degrade LRRK2, a protein implicated in Parkinson's Disease. The application covers pharmaceutical compositions and methods for treating LRRK2-associated disorders.